HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lütjohann, D. Articles by Heun, R. Search for Related Content PubMed PubMed Citation Articles by Lütjohann, D. Articles by Heun, R. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 195-198, February 2000
Copyright © 2000 by Lipid Research, Inc.

Original Article

Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients

Correspondence to: Dieter Lütjohann

Alzheimer's disease (AD) is characterized by the presence of senile plaques, neurofibrillary tangles, and neuronal cell loss associated with membrane cholesterol release. 24S-hydroxycholesterol (24S-OH-Chol) is an enzymatically oxidized product of cholesterol mainly synthesized in the brain. We tested the hypothesis that plasma levels of this oxysterol could be used as a putative biochemical marker for an altered cholesterol homeostasis in the brain of AD patients. Thirty patients with clinical criteria for AD, 30 healthy volunteers, 18 depressed patients, and 12 patients with vascular dementia (non-Alzheimer demented) were studied. Plasma concentrations of 24S-OH-Chol were assayed by isotope dilution;–mass spectrometry, cholesterol was measured enzymatically, and apolipoprotein E (apoE) was genotyped by polymerase chain reaction and restricted fragment length polymorphism. The concentration of 24S-OH-Chol in AD and non-Alzheimer demented patients was modestly but significantly higher than in healthy controls and in depressed patients. There was no significant difference in the concentrations of 24S-OH-Chol between depressed patients and healthy controls nor between AD and non-Alzheimer demented patients. The apoE 4 allele influences plasma 24S-OH-Chol. However, this influence could be completely accounted for by the elevated plasma cholesterol in apoE4 hetero- or homozygotes. Plasma 24S-OH-Chol levels correlated negatively with the severity of dementia. AD and vascular demented patients appear to have higher circulating levels of 24S-OH-Chol than depressed patients and healthy controls. We speculate that 24S-OH-Chol plasma levels may potentially be used as an early biochemical marker for an altered cholesterol homeostasis in the central nervous system.—Lütjohann, D., A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, R. D. Oehring, U. Schlegel, F. Jessen, M. L. Rao, K. von Bergmann, and R. Heun. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 2000. 41: 195;–198.

Supplementary key words: brain cholesterol, apolipoprotein E, cell membrane, isotope dilution;–mass spectrometry, hippocampus, senile plaques, depression, blood;–brain barrier

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. L. Gramajo, L. C. Zacharias, A. Neekhra, S. Luthra, S. R. Atilano, M. Chwa, D. J. Brown, B. D. Kuppermann, and M. C. Kenney Mitochondrial DNA Damage Induced by 7-Ketocholesterol in Human Retinal Pigment Epithelial Cells In Vitro Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 1164 - 1170. [Abstract] [Full Text] [PDF]

				C. Fourgeux, L. Martine, I. Bjorkhem, U. Diczfalusy, C. Joffre, N. Acar, C. Creuzot-Garcher, A. Bron, and L. Bretillon Primary Open-Angle Glaucoma: Association with Cholesterol 24S-Hydroxylase (CYP46A1) Gene Polymorphism and Plasma 24-Hydroxycholesterol Levels Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5712 - 5717. [Abstract] [Full Text] [PDF]

				J. M. Karasinska, F. Rinninger, D. Lutjohann, P. Ruddle, S. Franciosi, J. K. Kruit, R. R. Singaraja, V. Hirsch-Reinshagen, J. Fan, L. R. Brunham, et al. Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function J. Neurosci., March 18, 2009; 29(11): 3579 - 3589. [Abstract] [Full Text] [PDF]

				N. Mast, M. A. White, I. Bjorkhem, E. F. Johnson, C. D. Stout, and I. A. Pikuleva Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain PNAS, July 15, 2008; 105(28): 9546 - 9551. [Abstract] [Full Text] [PDF]

				H.-S. Hoe, M. J. Cooper, M. P. Burns, P. A. Lewis, M. van der Brug, G. Chakraborty, C. M. Cartagena, D. T. S. Pak, M. R. Cookson, and G. W. Rebeck The Metalloprotease Inhibitor TIMP-3 Regulates Amyloid Precursor Protein and Apolipoprotein E Receptor Proteolysis J. Neurosci., October 3, 2007; 27(40): 10895 - 10905. [Abstract] [Full Text] [PDF]

				V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF]

				R. M. Lane and M. R. Farlow Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease J. Lipid Res., May 1, 2005; 46(5): 949 - 968. [Abstract] [Full Text] [PDF]

				A. B. Reiss Cholesterol and apolipoprotein E in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 91 - 96. [Abstract] [PDF]

				J. Brown III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, et al. Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease J. Biol. Chem., August 13, 2004; 279(33): 34674 - 34681. [Abstract] [Full Text] [PDF]

				I. Bjorkhem and S. Meaney Brain Cholesterol: Long Secret Life Behind a Barrier Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 806 - 815. [Abstract] [Full Text]

				I. Burkard, K. M. Rentsch, and A. von Eckardstein Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry J. Lipid Res., April 1, 2004; 45(4): 776 - 781. [Abstract] [Full Text] [PDF]

				M. Heverin, N. Bogdanovic, D. Lutjohann, T. Bayer, I. Pikuleva, L. Bretillon, U. Diczfalusy, B. Winblad, and I. Bjorkhem Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease J. Lipid Res., January 1, 2004; 45(1): 186 - 193. [Abstract] [Full Text] [PDF]

				L. J Miller and R. Chacko The Role of Cholesterol and Statins in Alzheimer's Disease Ann. Pharmacother., January 1, 2004; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]

				R. L. Raffai and K. H. Weisgraber Cholesterol: from heart attacks to Alzheimer's disease J. Lipid Res., August 1, 2003; 44(8): 1423 - 1430. [Abstract] [Full Text] [PDF]

				G. L. Vega, M. F. Weiner, A. M. Lipton, K. von Bergmann, D. Lutjohann, C. Moore, and D. Svetlik Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease Arch Neurol, April 1, 2003; 60(4): 510 - 515. [Abstract] [Full Text] [PDF]

				U. Panzenboeck, Z. Balazs, A. Sovic, A. Hrzenjak, S. Levak-Frank, A. Wintersperger, E. Malle, and W. Sattler ABCA1 and Scavenger Receptor Class B, Type I, Are Modulators of Reverse Sterol Transport at an in Vitro Blood-Brain Barrier Constituted of Porcine Brain Capillary Endothelial Cells J. Biol. Chem., November 1, 2002; 277(45): 42781 - 42789. [Abstract] [Full Text] [PDF]

				N. ARISPE and M. DOH Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease A{beta}P (1-40) and (1-42) peptides FASEB J, October 1, 2002; 16(12): 1526 - 1536. [Abstract] [Full Text] [PDF]

				D. Lutjohann, A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, and T. A. Bayer Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain J. Lipid Res., July 1, 2002; 43(7): 1078 - 1085. [Abstract] [Full Text] [PDF]

				K. D. Whitney, M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J. Numerick, T. K. Tippin, J. G. Wilson, D. A. Winegar, and S. A. Kliewer Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System Mol. Endocrinol., June 1, 2002; 16(6): 1378 - 1385. [Abstract] [Full Text] [PDF]

				S. Locatelli, D. Lutjohann, H. H.-J. Schmidt, C. Otto, U. Beisiegel, and K. von Bergmann Reduction of Plasma 24S-Hydroxycholesterol (Cerebrosterol) Levels Using High-Dosage Simvastatin in Patients With Hypercholesterolemia: Evidence That Simvastatin Affects Cholesterol Metabolism in the Human Brain Arch Neurol, February 1, 2002; 59(2): 213 - 216. [Abstract] [Full Text] [PDF]

				J. Plat, H. Brzezinka, D. Lutjohann, R. P. Mensink, and K. von Bergmann Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry J. Lipid Res., December 1, 2001; 42(12): 2030 - 2038. [Abstract] [Full Text] [PDF]

				I. Bjorkhem, L. Starck, U. Andersson, D. Lutjohann, S. von Bahr, I. Pikuleva, A. Babiker, and U. Diczfalusy Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol J. Lipid Res., March 1, 2001; 42(3): 366 - 371. [Abstract] [Full Text]

				S. Meaney, M. Hassan, A. Sakinis, D. Lutjohann, K. von Bergmann, A. Wennmalm, U. Diczfalusy, and I. Bjorkhem Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study J. Lipid Res., January 1, 2001; 42(1): 70 - 78. [Abstract] [Full Text]

				L. Bretillon, D. Lutjohann, L. Stahle, T. Widhe, L. Bindl, G. Eggertsen, U. Diczfalusy, and I. Bjorkhem Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface J. Lipid Res., May 1, 2000; 41(5): 840 - 845. [Abstract] [Full Text]

				J. M. Dietschy and S. D. Turley Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J. Lipid Res., August 1, 2004; 45(8): 1375 - 1397. [Abstract] [Full Text] [PDF]